Recombinant Human IL-22 protein (His Tag)
ED50
/
Species
Human
Purity
>90 %, SDS-PAGE
GeneID
50616
Accession
Q9GZX6
验证数据展示
Technical Specifications
Purity | >90 %, SDS-PAGE |
Endotoxin Level | <1.0 EU/μg protein, LAL method |
Biological Activity |
Not tested |
Source | HEK293-derived Human IL-22 protein Met+Ala34-Ile179 (Accession# Q9GZX6) with a His tag at the N-terminus. |
Predicted Molecular Mass | 17.6 kDa |
SDS-PAGE | 20-27 kDa, reducing (R) conditions |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
Interleukin 22 (IL-22) is a member of the human type I interferon family, which includes IL10. IL-22 has the potential to interact with IL10 because it binds to the IL-10R2c chain with IL-22R1 in its receptor complex. Binding can be blocked by the soluble receptor, IL-22 binding protein (IL-22BP). Although known as a Th17 cytokine, IL-22 is also expressed by a wide range of immune cells, including NK T, γδ T, and NK cells. IL-22 can contribute to immune disease through the stimulation of inflammatory responses, S100s and defensins. IL-22 also promotes hepatocyte survival in the liver and epithelial cells in the lung and gut similar to IL-10.
References:
1. Pestka S. et al. (2004) Annu Rev Immunol. 22: 929-79. 2. Wolk K. et al. (2002) J Immunol 168(11): 5397-5402. 3. Zheng Y et al. (2007) Nature 445: 648-651. 4. Zheng Y et al. (2008) Nat Med 14: 282-289. 5. Xie MH, et al. (2000) J Biol Chem. 275: 31335-9. 6. Jones BC, et al. (2008) 16:1333-44.